Results 101 to 110 of about 50,512 (171)

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, Volume 600, Issue 21, Page 3265-3285, November 2026.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Imaging Early-Stage Metastases Using an 18F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant. [PDF]

open access: yesMol Imaging Biol, 2021
Mason CA   +9 more
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, Volume 20, Issue 11, Page 2741-2763, November 2026.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Further Insights Into the Mechanisms of Lymph Node Metastasis

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Metastasis of malignant tumors arising from epithelial organs to sentinel lymph nodes has important implications for prognosis, staging, and therapeutic decision‐making. Recent insights into anatomic pathways, pathogenesis, molecular interactions, and genetic factors have encouraged scientists and clinicians to develop drugs that target ...
S. David Nathanson   +5 more
wiley   +1 more source

VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. [PDF]

open access: yesMol Ther Methods Clin Dev, 2021
Bosco J   +19 more
europepmc   +1 more source

Redox and Inflammatory Mechanisms in PMOS and Endometriosis: A Critical Review of Microbial and Plant‐Derived Interventions

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 11, November 2026.
ABSTRACT Background Polycystic ovary syndrome (PCOS) or polyendocrine metabolic ovarian syndrome (PMOS) and endometriosis arise from different endocrine and tissue disturbances, yet oxidative stress (OS) and inflammation connect their initiating processes to reproductive dysfunction.
Afnan Athar Hussain   +11 more
wiley   +1 more source

Primary Cell‐Based Lymphatic Spheroids in Synthetic PEG Hydrogels: A Scalable Model of Lymphatic Sprouting

open access: yesJournal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 114, Issue 11, November 2026.
Primary lymphatic endothelial cells, lymphatic muscle cells, and human dermal fibroblasts self‐assemble into spheroids within defined, tunable PEG‐4MAL hydrogels, creating a bottom‐up sprouting assay. Rat collecting‐vessel spheroid sprouting peaks at intermediate stiffness (8% and 10% PEG‐4MAL), is rescued at low stiffness by VEGF‐C, and is suppressed ...
Yarelis Gonzalez‐Vargas   +7 more
wiley   +1 more source

Efficacy and Safety of ramucirumab Combined With Nab‐paclitaxel, Lobaplatin, and S‐1 in Conversion Therapy for Unresectable Advanced Gastric Cancer: Preliminary Results of Conversion Therapy Cohort of RNPLS‐01 Trial

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This study enrolled 70 HER2‐negative, unresectable stage III/IV gastric/gastroesophageal junction adenocarcinoma patients with over 6‐month survival, divided into RNPLS and NPLS groups (n = 35 each). Both groups received 21‐day‐cycle chemotherapy with lobaplatin, nab‐paclitaxel, and S‐1, while RNPLS additionally used ramucirumab.
Juan Wang   +12 more
wiley   +1 more source

Ovarian Carcinoma: Signal Pathways and Clinical Studies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This review synthesizes current knowledge on the pathophysiological mechanisms driven by the Notch, HER2, DNA damage repair (DDR), PI3K/AKT/mTOR, and angiogenesis (VEGF) pathways in ovarian cancer. A key focus is placed on summarizing subsequent targeted therapeutic strategies, detailing the landscape of associated clinical trials and their ...
Yanru Long   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy